The Biden-Harris administration in the US has announced a new “Time is Money” initiative that aims to tackle “junk fees” and bad service in several sectors, including healthcare.

Part of the administration’s action plan includes allowing patients to submit health claims online. The 12 August factsheet lamented that several of the largest healthcare plans still require people to print out and scan or physically mail health insurance claim forms.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

In a letter on the initiative, Health and Human Services (HHS) Secretary Xavier Becerra said that the new plan should also prioritise measures such as improving the accessibility of critical information about in-network clinicians and facilities and prescription drug formularies. He added that “helping individuals enrol in the right plan by streamlining processes and providing clear, digestible information about health coverage” should also take precedence.

The new initiative arrives following a Kaiser Family Foundation survey that found that 58% of people with health coverage reported at least one problem using their coverage in the last year.

The new initiative has been met with some criticism. US Chamber of Commerce executive vice-president Neil Bradley said: “While we agree on the problem of all-too-high costs for American families, the regulatory burden unleashed by the so-called ‘Time is Money’ initiative will cost the American people more time and money.”

Aside from healthcare, the Biden administration also outlined plans to simplify the cancellation of subscription services and memberships, as well as make companies more accountable for their bad service. The latter action, proposed by the Federal Trade Commission (FTC), would institute a rule that prevents marketers from using illicit review and endorsement practices to deceive consumers.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Alongside the 12 August factsheet, the White House has launched a portal, asking for public opinions surrounding the aforementioned issues.

Pharmaceutical Technology Excellence Awards - Nominations Closed

Nominations are now closed for the Pharmaceutical Technology Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Imagene’s Oncology Intelligence (OI) Suite has won the Innovation Award for Precision Oncology, for transforming how pharma designs and runs oncology trials. From AI-driven biomarker discovery to smarter patient stratification, see how Imagene is cutting time, cost and risk in cancer drug development.

Discover the Impact